Richard J. Robbins, MD

Charles and Anne Duncan Presidential Distinguished Chair, Department of Medicine
Professor of Medicine, Institute for Academic Medicine
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Robbins is chairman of the Department of Medicine at Houston Methodist Hospital where he holds the Charles and Anne Duncan Presidential Distinguished Chair in Medicine. He also has an appointments at Weill Medical College of Cornell University and the Institute for Academic Medicine as Professor of Medicine. His current research focuses on defining the natural history, exploring diagnostic strategies, and developing novel diagnostic and targeted therapies for patients with thyroid cancer.

Dr. Robbins is a graduate of the University of Dayton in Ohio, and the Creighton University School of Medicine in Omaha, Nebraska. He received his internal medicine training at The New York Hospital-Cornell Medical Center and completed an Endocrinology fellowship at Tufts-New England Medical Center in Boston. He has held faculty positions at the University of Colorado, Yale Medical School, and came to Houston Methodist from his post as associate chair of medicine for academic affairs, and chief of the endocrine service, at Memorial Sloan Kettering Cancer Center.

Dr. Robbins founded and has served on the board of the Pituitary Society and is the recipient of its Distinguished Service Award. In addition to numerous other awards and honors throughout his career, Dr. Robbins has more than 120 peer-reviewed publications in leading journals such as Nature, Science, and the New England Journal of Medicine. He currently serves on the editorial board of the American Journal of Medicine.

Description of Research

Dr. Robbins has served as principal investigator or co-investigator of multiple basic science studies and clinical trials. His current research focuses on defining the natural history, exploring diagnostic strategies, and developing novel targeted therapies for patients with thyroid carcinoma.

Areas Of Expertise

Thyroid cancer
Education & Training

Clinical Fellowship, Tufts University Medical School
Residency, Weill Cornell Medical College
MD, Creighton University School of Medicine
Publications

Extreme hypercholesterolemia in cholestatic sarcoidosis due to lipoprotein X: Exploring the cholesterol gap
Yehya, A, Huang, R, Bernard, DW, Gotto, A & Robbins, RJ 2018, Journal of Clinical and Translational Endocrinology: Case Reports, vol. 10, pp. 11-13. https://doi.org/10.1016/j.jecr.2018.08.002

Extreme hypercholesterolemia in cholestatic sarcoidosis due to lipoprotein X: Exploring the cholesterol gap
Yehya, A, Huang, R, Bernard, DW, Gotto, A & Robbins, RJ 2018, Journal of Clinical and Translational Endocrinology: Case Reports, vol. 10, pp. 11-13. https://doi.org/10.1016/j.jecr.2018.08.002

Update on Management of Type 2 Diabetes for Cardiologists
Qureshi, M, Gammoh, E, Shakil, J & Robbins, RJ 2018, Methodist DeBakey cardiovascular journal, vol. 14, no. 4, pp. 273-280. https://doi.org/10.14797/mdcj-14-4-273

Pancreas metastases from papillary thyroid carcinoma: A review of the literature
Davidson, M, Olsen, RJ, Ewton, AA & Robbins, RJ 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 23, no. 12, pp. 1425-1429. https://doi.org/10.4158/EP-2017-0001

Comparison of Direct Patient Care Costs and Quality Outcomes of the Teaching and Nonteaching Hospitalist Services at a Large Academic Medical Center
Perez Perez, JA, Awar, M, Nezamabadi, A, Ogunti, R, Puppala, M, Colton, L, Clewing, JM, Ketkar, S, Wong, STC & Robbins, RJ 2018, Academic medicine : journal of the Association of American Medical Colleges, pp. 491-497. https://doi.org/10.1097/ACM.0000000000002026

Cardiovascular Disease in Acromegaly
Sharma, MD, Nguyen, AV, Brown, S & Robbins, RJ 2017, Methodist DeBakey Cardiovascular Journal, vol. 13, no. 2, pp. 64-67. https://doi.org/10.14797/mdcj-13-2-64

Guest Editors Richard Robbins and Steven Petak Provide Oversight & Expertise for Special Issue on Hormones and the Heart
Robbins, R & Petak, S 2017, Methodist DeBakey Cardiovascular Journal, vol. 13, no. 2, pp. 47. https://doi.org/10.14797/mdcj-13-2-47

Testosterone and the Heart
Goodale, T, Sadhu, A, Petak, S & Robbins, R 2017, Methodist DeBakey Cardiovascular Journal, vol. 13, no. 2, pp. 68-72. https://doi.org/10.14797/mdcj-13-2-68

Hormones and the Heart
Robbins, RJ & Petak, S 2017, Methodist DeBakey Cardiovascular Journal, vol. 13, no. 2, pp. 48. https://doi.org/10.14797/mdcj-13-2-48

LOWER RATES OF RESIDUAL/RECURRENT DISEASE IN PATIENTS WITH INCIDENTALLY DISCOVERED THYROID CARCINOMA
Shakil, J, Ansari, MZ, Brady, JR, Xu, J & Robbins, RJ 2017, Endocrine Practice, vol. 23, no. 2, pp. 163-169. https://doi.org/10.4158/EP161497.OR

The costs of training internal medicine residents in the United States
Ben-Ari, R, Robbins, RJ, Pindiprolu, S, Goldman, A & Parsons, PE 2014, American Journal of Medicine, vol. 127, no. 10, pp. 1017-1023. https://doi.org/10.1016/j.amjmed.2014.06.040

Hürthle cell carcinoma of the thyroid presenting as thyrotoxicosis
Karanchi, H, Hamilton, DJ & Robbins, RJ 2012, Endocrine Practice, vol. 18, no. 1. https://doi.org/10.4158/EP11142.CR

Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH
Tala, H, Robbins, RJ, Fagin, JA, Larson, SM & Tuttle, RM 2011, Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 2105-2111. https://doi.org/10.1210/jc.2011-0305

The cardiovascular effects of hyperthyroidism.
Nabbout, LA & Robbins, RJ 2010, Methodist DeBakey Cardiovascular Journal, vol. 6, no. 2, pp. 3-8.

Reply: A new age for recombinant human thyroid-stimulating hormone?
Tuttle, RM, Robbins, RJ, Brokhin, M & Larson, SM 2009, Journal of Nuclear Medicine, vol. 50, no. 5, pp. 832-833. https://doi.org/10.2967/jnumed.108.060400

The value of positron emission tomography (PET) in the management of patients with thyroid cancer
Robbins, RJ & Larson, SM 2008, Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 22, no. 6, pp. 1047-1059. https://doi.org/10.1016/j.beem.2008.10.001

Expanding indications for recombinant human TSH in thyroid cancer
Haugen, BR, Cooper, DS, Emerson, CH, Luster, M, Maciel, RMB, Biscolla, RPM, Mazzaferri, EL, Medeiros-Neto, G, Reiners, C, Robbins, RJ, Robinson, BG, Schlumberger, M, Yamashita, S & Pacini, F 2008, Thyroid, vol. 18, no. 7, pp. 687-694. https://doi.org/10.1089/thy.2008.0162

Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal
Tuttle, RM, Brokhin, M, Omry, G, Martorella, AJ, Larson, SM, Grewal, RK, Fleisher, M & Robbins, RJ 2008, Journal of Nuclear Medicine, vol. 49, no. 5, pp. 764-770. https://doi.org/10.2967/jnumed.107.049072

A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery
Villanueva, J, Nazarian, A, Lawlor, K, Yi, SS, Robbins, RJ & Tempst, P 2008, Molecular and Cellular Proteomics, vol. 7, no. 3, pp. 509-518. https://doi.org/10.1074/mcp.M700397-MCP200

Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib [3]
Feldman, DR, Martorella, AJ, Robbins, RJ & Motzer, RJ 2007, Journal of the National Cancer Institute, vol. 99, no. 12, pp. 974-975. https://doi.org/10.1093/jnci/djm006

Live Chat Available